ALBEMARLE CORP

Albemarle's capital structure shows a debt-to-equity ratio of 0.33, indicating a relatively conservative leverage position. The company maintains a strong liquidity position with a current ratio of 2.23 and cash and equivalents of $1.93 billion. However, the company's operating cash flow of $1.28 billion and free cash flow of $692 million are offset by a net loss of $511 million, suggesting operational challenges. Profitability metrics are concerning, with a negative return on equity of -5.36% and a return on assets of -3.12%. These figures fall significantly below the industry median for specialty chemicals, which typically exhibit positive returns. The company's gross profit of $669 million is also below the industry average, indicating potential cost management issues or pricing pressures. Geographically, Albemarle's revenue is concentrated in the Energy Storage segment, which focuses on lithium compounds for energy storage applications. The Specialties segment serves a broad range of industries, including energy, mobility, and health, while the Ketjen segment includes performance catalyst solutions. The company's exposure to the refining market through its joint venture adds another layer of complexity to its revenue streams. Growth trajectory is mixed, with a revenue decline in the nine months ended September 30, 2025, compared to the same period in 2024. The company reported net sales of $3.71 billion in the nine months ended September 30, 2025, down from $4.15 billion in the same period in 2024. This decline is attributed to cyclical demand in the industries it serves and increased costs, which could reduce product demand. Risk factors include medium liquidity and dilution risks. The company's net cash is negative after subtracting total debt, and source documents mention dilution or offering risk. The risk assessment also highlights potential dilution from recent issuance activities and the possibility of future offerings. Recent events include a significant goodwill impairment charge of $181 million in the nine months ended September 30, 2025, and restructuring charges and asset write-offs of $5.7 million. The company also reported a net loss attributable to Albemarle Corporation of $221 million for the nine months ended September 30, 2025, compared to a net loss of $1.35 billion in the same period in 2024. These events reflect ongoing operational and financial challenges.